Personal profile
Diplomas
Areas of expertise
Awards
Alfers Prize 2022
Namurois de l'année 2019
Eberhard F. Mammen - Young Investigator Award 2019
Prix Léo Pharma 2017 - Cancer et Thrombose
XXIV Congress of the International Society on Thrombosis and Haemostasis - Young Investigator Award
58th Annual SSC Meeting of the International Society on Thrombosis and Haemostasis - Young Investigator Award
55th American Society of Hematology Annual Meeting and Exposition - Abstract Achievement Award
56th American Society of Hematology Annual Meeting and Exposition - Abstract Achievement Award
External responsibilities
CSO and Director of the Board of QUALIblood sa
Co-Chairman of the SSC Control of Anticoagulation of the Interntional Society on Thrombosis and Hemostasis
Pharmacovigilance Expert at the Federal Agency of Medicines and Health Products
Member of Expert Team Haemostasis Diagnostics at the ECAT Foundation
Member of the Expert Committee of the Assemblée Scientifique des Pharmaciens Francophones
Education/Academic qualification
Doctor of Pharmacy, University of Namur
Award Date: 24 Oct 2015
Master of Pharmacy, Université Catholique de Louvain
Award Date: 24 Jun 2011
Bachelor of Pharmacy, University of Namur
Award Date: 4 Sept 2009
External positions
Member of the Expert Team Haemostasis Diagnostics, ECAT Foundation
Nov 2019 → …
Chief Executive Officer, Qualiblood
Nov 2017 → …
Co-Chairman, International Society on Thrombosis and Haemostasis
Nov 2016 → …
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
NeutroLab project: Exploring neutrophil dynamics and NETosis in health and disease
Gillot, C. (PI), Michaux, P. (Researcher), Douxfils, J. (PI), Debroux, M. (Technician) & Bouarroudj, H. (Researcher)
1/01/24 → …
Project: Research Axis
-
NucleoGlio (BioWin): Development of a diagnostic test for glioblastoma and follow-up of patients
Douxfils, J. (PI)
1/11/23 → 31/10/27
Project: Research
-
PALPITATION: The platelet lipidome, a promising diagnostic or therapeutic option for HFpEF patients
Horman, S. (PI), POULEUR, A.-C. (CoPI), Dessy, C. (CoPI) & Douxfils, J. (CoPI)
1/10/23 → 30/09/28
Project: Research
-
Management of (activated) factor eleven (FXI(a)) inhibitors
Vassart, J. (Researcher), Douxfils, J. (PI) & Dogné, J.-M. (Co-supervisor)
17/10/22 → …
Project: PHD
-
Abelacimab and osocimab: Pharmacodynamic insights from coagulation assays
Vassart, J., Minguet, R., Brisbois, C. & Douxfils, J., 2 Mar 2026, p. 138-140.Research output: Contribution to conference › Poster
File12 Downloads (Pure) -
Abelacimab and osocimab: What impact on laboratory coagulation assays?
Vassart, J., Minguet, R., Brisbois, C. & Douxfils, J., 2 Mar 2026, p. 137-138.Research output: Contribution to conference › Poster
File15 Downloads (Pure) -
A detailed review of pharmacokinetics/pharmacodynamics of progestogens in oral contraception
Gaspard, U., Chatel, G., Douxfils, J. & Stanczyk, F. Z., 26 Mar 2026, In: Frontiers in endocrinology. 17, p. 1730768Research output: Contribution to journal › Review article › peer-review
File2 Downloads (Pure) -
Critical assessment of a prolonged-release eE/DNG contraceptive safety analysis
Douxfils, J., Chabbert-Buffet, N., Creinin, M. D., Didembourg, M., Dogné, J.-M., Foidart, J.-M., Gaspard, U., Heikinheimo, O., Lidegaard, Ø., Locquet, M., Morimont, L., Raskin, L., Gemzell Danielsson, K. & Kopp-Kallner, H., 17 Feb 2026, (E-pub ahead of print) In: The European journal of contraception & reproductive health care. p. 1-4 4 p.Research output: Contribution to journal › Letter › peer-review
-
Evaluation of DOAC Dipstick Performance for Plasma Concentration Thresholds of 50, 70, and 100 ng/mL.
Harenberg, J. F., Merrelaar, A. E., Schwameis, M., Herkner, H., Hetjens, S., Weiss, C., Vassart, J., Douxfils, J., Tafur, A., Koscielny, J. & Langer, F., 19 Feb 2026, p. S27-S28.Research output: Contribution to conference › Poster
File5 Downloads (Pure)
Datasets
-
Risk of arterial and venous occlusive events in chronic myeloid leukemia patients treated with new generation BCR-ABL tyrosine kinase inhibitors: a systematic review and meta-analysis
Graux, C. (Contributor), Chatelain, C. (Contributor), Mullier, F. (Contributor), Haguet, H. (Contributor), DOGNE, J.-M. (Contributor) & Douxfils, J. (Contributor), Figshare, 29 Nov 2016
DOI: 10.6084/m9.figshare.4265168.v1, https://figshare.com/articles/Risk_of_arterial_and_venous_occlusive_events_in_chronic_myeloid_leukemia_patients_treated_with_new_generation_BCR-ABL_tyrosine_kinase_inhibitors_a_systematic_review_and_meta-analysis/4265168/1 and one more link, https://ndownloader.figshare.com/files/6948968 (show fewer)
Dataset
Prizes
-
55th ASH Annual Meeting and Exposition - Abstract Achievement Award
Douxfils, J. (Recipient), 7 Dec 2013
Prize: Prize (including medals and awards)
-
56th ASH Annual Meeting and Exposition - Abstract Achievement Award
Douxfils, J. (Recipient), 6 Dec 2014
Prize: Prize (including medals and awards)
-
58th Annual SSC Meeting of the ISTH - Young Investigators Awards
Douxfils, J. (Recipient), 26 Jun 2012
Prize: Prize (including medals and awards)
-
Alfers 2022 - Prix de l'innovation
Douxfils, J. (Recipient), 24 May 2022
Prize: Prize (including medals and awards)
-
Eberhard F. Mammen Young Investigator Award 2019
Douxfils, J. (Recipient), 2019
Prize: National/international honour
Activities
-
From Biomarkers to Real-World Evidence: Reframing VTE Risk with Combined Oral Contraceptives (COCs)
Douxfils, J. (Speaker)
14 Apr 2026Activity: Talk or presentation types › Invited talk
-
Sécurité vasculaire des traitements hormonaux dans l'endométriose.
Douxfils, J. (Speaker)
2 Apr 2026Activity: Talk or presentation types › Invited talk
-
Vascular risk of hormonal therapies in Endometriosis
Douxfils, J. (Speaker)
9 Apr 2026Activity: Talk or presentation types › Invited talk
-
Should we be afraid of hormonal treatments?
Douxfils, J. (Speaker)
10 Apr 2026Activity: Talk or presentation types › Invited talk
-
Risque vasculaire des thérapies hormonales utilisées dans l'endométriose - Évolution de ma pratique : pour quelles patientes utiliser les traitements de seconde intention ?
Douxfils, J. (Speaker)
9 Apr 2026Activity: Talk or presentation types › Invited talk
Thesis
-
Evaluation of thrombotic and/or bleeding risks associated with anticoagulotherapy.
Douxfils, J. (Author), Dogne, J.-M. (Supervisor), Mullier, F. (Supervisor), Masereel, B. (President), Chatelain, B. (Jury), Chatelain, C. (Jury), Verhamme, P. (Jury), TEN CATE, H. (Jury) & Ageno, W. (Jury), 24 Oct 2015Student thesis: Doc types › Doctor of Biomedical and Pharmaceutical Sciences
-
Therapeutic monitoring of new oral anticoagulant: focus on dabigatran
Douxfils, J. (Author), Dogne, J.-M. (Supervisor), 2012Student thesis: Master types › Master in Pharmacy
Press/Media
-
Research on Thromboembolism Described by Researchers at University of Liege (A detailed review of pharmacokinetics/pharmacodynamics of progestogens in oral contraception)
13/04/26
1 item of Media coverage
Press/Media: Expert Comment
-
Reports from University of Namur Describe Recent Advances in Venous Thromboembolism (Venous Thromboembolism with Combined Oral Contraceptives Based on Estrogen and Progestin Content: A disproportionality analysis of the United States Food and ...)
Dogné, J.-M., Douxfils, J., Didembourg, M., Beaudart, C. & Locquet, M.
13/03/26
1 item of Media coverage
Press/Media: Expert Comment
-
Experts believe that current criteria for polycystic ovary syndrome may lead to overdiagnosis.
4/03/26
1 item of Media coverage
Press/Media: Expert Comment
-
Experts believe that current criteria for polycystic ovary syndrome may lead to overdiagnosis.
4/03/26
1 item of Media coverage
Press/Media: Expert Comment
-
Studies from University of Namur Have Provided New Data on Menopause (Patient Preferences Regarding Menopausal Symptoms and Treatments: A Systematic Review of Quantitative Stated-Preference Studies)
20/02/26
1 item of Media coverage
Press/Media: Expert Comment